Position in CPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,528,399
-$4,986,593 QoQ
Shares Held
142,504
-60.9% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $506,574,956 across 170 Biotechnology names. CPRX ranks #33 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,491 | $108,548,965 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
131,560 | $58,746,801 | |
| 3 | INCY |
Incyte Corp
|
374,280 | $35,227,233 | |
| 4 | EXEL |
Exelixis, Inc.
|
463,825 | $19,893,454 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
64,133 | $12,804,153 | |
| 6 | ALMS |
Alumis Inc.
|
538,733 | $11,868,287 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
164,570 | $11,212,154 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
95,235 | $10,037,769 |
All Filings in CPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,528,399 | 142,504 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,514,992 | 364,824 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,935,041 | 402,794 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,167,532 | 376,384 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $9,243,712 | 381,184 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,549,958 | 553,424 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $8,446,992 | 424,899 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,021,463 | 195,059 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,629,362 | 227,689 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,670,126 | 218,330 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,726,892 | 575,440 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,504,821 | 707,204 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $12,345,616 | 744,609 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $15,194,154 | 816,890 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $19,150,377 | 1,492,625 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $8,994,144 | 1,283,045 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,833,518 | 1,427,445 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,484,163 | 1,253,200 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,775,485 | 1,655,752 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,094,544 | 1,929,486 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $12,673,714 | 2,749,179 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $8,922,264 | 2,671,337 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $7,270,075 | 2,447,837 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $6,568,480 | 1,421,749 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $3,963,451 | 1,029,468 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||